First-trimester irisin and fetuin-A concentration in predicting macrosomia

References

• Gicquel C, Le Bouc Y. Hormonal regulation of fetal growth. Horm Res. 2006;65(Suppl 3):28–33.
   PubMedGoogle Scholar
• Jansson T, Powell TL. IFPA 2005 Award in Placentology Lecture. Human placental transport in altered fetal growth: does the placenta function as a nutrient sensor? – a review. Placenta. 2006;27(Suppl A):S91–S97.
   PubMed Web of Science ®Google Scholar
• Nohr EA, Vaeth M, Baker JL, et al. Pregnancy outcomes related to gestational weight gain in women defined by their body mass index, parity, height, and smoking status. Am J Clin Nutr. 2009;90(5):1288–1294.
   PubMed Web of Science ®Google Scholar
• Lain KY, Catalano PM. Factors that affect maternal insulin resistance and modify fetal growth and body composition. Metab Syndr Relat Disord. 2006; 4(2):91–100.
   PubMedGoogle Scholar
• Kramer MS, Morin I, Yang H, et al. Why are babies getting bigger? Temporal trends in fetal growth and its determinants. J Pediatr. 2002;141(4):538–542.
   PubMed Web of Science ®Google Scholar
• Catalano PM, Hauguel-De Mouzon S. Is it time to revisit the Pedersen hypothesis in the face of the obesity epidemic? Am J Obstet Gynecol. 2011; 204(6):479–487.
   PubMed Web of Science ®Google Scholar
• Bjørstad AR, Irgens-Hansen K, Daltveit AK, et al. Macrosomia: mode of delivery and pregnancy outcome. Acta Obstet Gynecol Scand. 2010;89(5): 664–669.
   PubMed Web of Science ®Google Scholar
• Boney CM, Verma A, Tucker R, et al. Metabolic syndrome in childhood: association with birth weight, maternal obesity, and gestational diabetes mellitus. Pediatrics. 2005;115(3):e290–e296.
   PubMed Web of Science ®Google Scholar
• Leung TY, Sahota DS, Chan LW, et al. Prediction of birth weight by fetal crown-rump length and maternal serum levels of pregnancy-associated plasma protein-A in the first trimester. Ultrasound Obstet Gynecol. 2008;31(1):10–14.
   PubMed Web of Science ®Google Scholar
• Kirkegaard I, Henriksen TB, Uldbjerg N. Early fetal growth, PAPP-A and freeβ-hCG in relation to risk of delivering a small-for-gestational age infant. Ultrasound Obstet Gynecol. 2011;37(3):341–347.
   PubMed Web of Science ®Google Scholar
• Plasencia W, González Dávila E, Tetilla V, et al. First-trimester screening for large-for-gestational-age infants. Ultrasound Obstet Gynecol. 2012;39(4):389–395.
   PubMed Web of Science ®Google Scholar
• Poon LC, Karagiannis G, Stratieva V, et al. First-trimester prediction of macrosomia. Fetal Diagn Ther. 2011;29(2):139–147.
   PubMed Web of Science ®Google Scholar
• Boldt HB, Conover CA. Pregnancy-associated plasma protein-A (PAPP-A): a local regulator of IGF bioavailability through cleavage of IGFBPs. Growth Horm IGF Res. 2007;17(1):10–18.
   PubMed Web of Science ®Google Scholar
• Retnakaran R, Ye C, Hanley AJ, et al. Effect of maternal weight, adipokines, glucose intolerance and lipids on infant birth weight among women without gestational diabetes mellitus. CMAJ. 2012;184(12): 1353–1360.
   PubMed Web of Science ®Google Scholar
• Jansson N, Nilsfelt A, Gellerstedt M, et al. Maternal hormones linking maternal body mass index and dietary intake to birth weight. Am J Clin Nutr. 2008; 87(6):1743–1749.
   PubMed Web of Science ®Google Scholar
• Wang J, Shang LX, Dong X, et al. Relationship of adiponectin and resistin levels in umbilical serum, maternal serum and placenta with neonatal birth weight. Aust N Z J Obstet Gynaecol. 2010;50(5):432–438.
   PubMed Web of Science ®Google Scholar
• Hauguel-de Mouzon S, Lepercq J, Catalano P. The known and unknown of leptin in pregnancy. Am J Obstet Gynecol. 2006;194(6):1537–1545.
   PubMed Web of Science ®Google Scholar
• Misra VK, Straughen JK, Trudeau S. Maternal serum leptin during pregnancy and infant birth weight: the influence of maternal overweight and obesity. Obesity (Silver Spring). 2013;21(5):1064–1069.
   PubMed Web of Science ®Google Scholar
• Hedley P, Pihl K, Krebs L, et al. Leptin in first trimester pregnancy serum: no reduction associated with small-for-gestational-age infants. Reprod Biomed Online. 2009;18(6):832–837.
   PubMed Web of Science ®Google Scholar
• Mise H, Yura S, Itoh H, et al. The relationship between maternal plasma leptin levels and fetal growth restriction. Endocr J. 2007;54(6):945–951.
   PubMed Web of Science ®Google Scholar
• Clausen T, Burski TK, Øyen N, et al. Maternal anthropometric and metabolic factors in the first half of pregnancy and risk of neonatal macrosomia in term pregnancies. A prospective study. Eur J Endocrinol. 2005;153(6):887–894.
   PubMed Web of Science ®Google Scholar
• Shroff MR, Holzman C, Tian Y, et al. Mid-pregnancy maternal leptin levels, birthweight for gestational age and preterm delivery. Clin Endocrinol (Oxf). 2013; 78(4):607–613.
   PubMed Web of Science ®Google Scholar
• Ciborowski M, Zbucka-Kretowska M, Bomba-Opon D, et al. Potential first trimester metabolomic biomarkers of abnormal birth weight in healthy pregnancies. Prenat Diagn. 2014;34(9):870–877.
   PubMed Web of Science ®Google Scholar
• Boström P, Wu J, Jedrychowski MP, et al. A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature. 2012;481(7382):463–468.
   PubMed Web of Science ®Google Scholar
• Roca-Rivada A, Castelao C, Senin LL, et al. FNDC5/irisin is not only a myokine but also an adipokine. PLoS One. 2013;8(4):e60563.
   PubMed Web of Science ®Google Scholar
• Briana DD, Boutsikou M, Athanasopoulos N, et al. Implication of the myokine irisin in maternal energy homeostasis in pregnancies with abnormal fetal growth. J Matern Fetal Neonatal Med. 2016;29(21): 3429–3433.
   PubMed Web of Science ®Google Scholar
• Baka S, Malamitsi-Puchner A, Boutsikou T, et al. Cord blood irisin at the extremes of fetal growth. Metabolism. 2015;64(11):1515–1520.
   PubMed Web of Science ®Google Scholar
• Joung KE, Park KH, Filippaios A, et al. Cord blood irisin levels are positively correlated with birth weight in newborn infants. Metabolism. 2015;64(11):1507–1514.
   PubMed Web of Science ®Google Scholar
• Stefan N, Hennige AM, Staiger H, et al. α2-Heremans-Schmid glycoprotein /fetuin-A is associated with insulin resistance and fat accumulation in the liver in humans. Diabetes Care. 2006;29(4):853–857.
   PubMed Web of Science ®Google Scholar
• Mathews ST, Chellam N, Srinivas PR, et al. α2-HSG, a specific inhibitor of insulin receptor autophosphorylation, interacts with the insulin receptor. Mol Cell Endocrinol. 2000;164(1–2):87–98.
   PubMed Web of Science ®Google Scholar
• Stefan N, Fritsche A, Weikert C, et al. Plasma fetuin-A levels and the risk of type 2 diabetes. Diabetes. 2008;57(10):2762–2767.
   PubMed Web of Science ®Google Scholar
• Schafer C, Heiss A, Schwarz A, et al. The serum protein α2-Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification. J Clin Invest. 2003;112(3):357–366.
   PubMed Web of Science ®Google Scholar
• Jahnen-Dechent W, Heiss A, Schäfer C, et al. Fetuin-A regulation of calcified matrix metabolism. Circ Res. 2011;108(12):1494–1509.
   PubMed Web of Science ®Google Scholar
• Kalabay L, Cseh K, Pajor A, et al. Correlation of maternal serum fetuin/α2-HS-glycoprotein concentration with maternal insulin resistance and anthropometric parameters of neonates in normal pregnancy and gestational diabetes. Eur J Endocrinol. 2002;147(2): 243–248.
   PubMed Web of Science ®Google Scholar
• Briana DD, Boutsikou M, Gourgiotis D, et al. Serum fetuin-A/alpha2-HS-glycoprotein in human pregnancies with normal and restricted fetal growth. J Matern Fetal Neonatal Med. 2008;21(11):826–830.
   PubMed Web of Science ®Google Scholar
• Iliodromiti S, Vrachnis N, Samoli E, et al. Fetuin A concentration in the second trimester amniotic fluid of fetuses with trisomy 21 appears to be lower: phenotypic considerations. Mediators Inflamm. 2012;2012: 138971.
   PubMed Web of Science ®Google Scholar
• Shore VH, Wang TH, Wang CL, et al. Vascular endothelial growth factor, placenta growth factor and their receptors in isolated human trophoblast. Placenta. 1997;18(8):657–665.
   PubMed Web of Science ®Google Scholar
• Poon LC, Zaragoza E, Akolekar R, et al. Maternal serum placental growth factor (PlGF) in small for gestational age pregnancy at 11(+0) to 13(+6) weeks of gestation. Prenat Diagn. 2008;28(12):1110–1115.
   PubMed Web of Science ®Google Scholar
• Bergen NE, Bouwland-Both MI, Steegers-Theunissen RP, et al. Early pregnancy maternal and fetal angiogenic factors and fetal and childhood growth: the Generation R Study. Hum Reprod. 2015;30(6): 1302–1313.
   PubMed Web of Science ®Google Scholar
• Sundrani D, Khot V, Pisal H, et al. Gestation dependant changes in angiogenic factors and their associations with fetal growth measures in normotensive pregnancy. PLoS One. 2013;8(1):e54153.
   PubMed Web of Science ®Google Scholar
• James-Todd T, Cohen A, Wenger J, et al. Time-specific placental growth factor (PlGF) across pregnancy and infant birth weight in women with preexisting diabetes. Hypertens Pregnancy. 2016;35(3):436–446.
   PubMed Web of Science ®Google Scholar
• Kuc S, Wortelboer EJ, Koster MP, et al. Prediction of macrosomia at birth in type-1 and 2 diabetic pregnancies with biomarkers of early placentation. BJOG. 2011;118(6):748–754.
   PubMed Web of Science ®Google Scholar
• Gąsiorowska A, Pietryga M, Zawiejska A, et al. Chorionic thickness and PlGF concentrations as early predictors of small-for-gestational age birth weight in a low risk population. Ginekol Pol. 2017; 88(2):87–95.
   PubMed Web of Science ®Google Scholar
• Law LW, Leung TY, Sahota DS, et al. Which ultrasound or biochemical markers are independent predictors of small-for-gestational age? Ultrasound Obstet Gynecol. 2009;34(3):283–287.
   PubMed Web of Science ®Google Scholar
• Crovetto F, Crispi F, Scazzocchio E, et al. First-trimester screening for early and late small-for-gestational-age neonates using maternal serum biochemistry, blood pressure and uterine artery Doppler. Ultrasound Obstet Gynecol. 2014;43(1):34–40.
   PubMed Web of Science ®Google Scholar
• Goetzinger KR, Singla A, Gerkowicz S, et al. The efficiency of first-trimester serum analytes and maternal characteristics in predicting fetal growth disorders. Am J Obstet Gynecol. 2009;201(4):412.e1–412.e6.
   PubMed Web of Science ®Google Scholar
• Cortelazzi D, Corbetta S, Ronzoni S, et al. Maternal and foetal resistin and adiponectin concentrations in normal and complicated pregnancies. Clin Endocrinol (Oxf). 2007;66(3):447–453.
   PubMed Web of Science ®Google Scholar
• Ornoy A. Biomarkers of maternal diabetes and its complication in pregnancy. Reprod Toxicol. 2012; 34(2):174–179.
   PubMed Web of Science ®Google Scholar
• Wang J, Wang SH, Shang LX, et al. Relationship of adiponectin and resistin levels in umbilical and maternal serum with fetal macrosomia. J Obstet Gynaecol Res. 2010;36(3):533–537.
   PubMed Web of Science ®Google Scholar
• Vernini JM, Moreli JB, Costa RA, et al. Maternal adipokines and insulin as biomarkers of pregnancies complicated by overweight and obesity. Diabetol Metab Syndr. eCollection. 2016;8(1):68.
   PubMed Web of Science ®Google Scholar
• Nanda S, Poon LC, Muhaisen M, et al. Maternal serum resistin at 11 to 13 weeks’ gestation in normal and pathological pregnancies. Metabolism. 2012;61(5): 699–705.
   PubMed Web of Science ®Google Scholar